Par Pharmaceutical Companies, Inc. develops, manufactures, and markets generic drugs and innovative branded pharmaceuticals for specialty markets. In July 2005, Par received approval for and introduced Megace ES, the company's first branded pharmaceutical product. We expect to launch our second branded product some time in 2006. Our Generic Products Division is committed to providing high-quality pharmaceuticals that are affordable and accessible to patients. Par ranks fifth in sales among all U...
more>>